CAESARS ENTERTAINMENT INC (CZR) Forecast, Price Target & Analyst Ratings
NASDAQ:CZR • US12769G1004
28.41 USD
-0.66 (-2.27%)
At close: Mar 12, 2026
28.3801 USD
-0.03 (-0.11%)
After Hours: 3/12/2026, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CAESARS ENTERTAINMENT INC (CZR).
Forecast Snapshot
Consensus Price Target
$34.26
+ 20.60% Upside
Next Earnings Forecast
Release DateApr 27, 2026
PeriodQ1 / 2026
EPS Estimate-$0.26
Revenue Estimate2.871B
ChartMill Buy Consensus
76.80%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$34.26
Upside
+ 20.60%
From current price of $28.41 to mean target of $34.26, Based on 25 analyst forecasts
Low
$22.22
Median
$33.66
High
$64.29
Price Target Revisions
1 Month
-4.63%
3 Months
-5.14%
Price Target Summary
25 Wall Street analysts provided a forecast for the next 12 months for CZR. The average price target is 34.26 USD. This implies a price increase of 20.6% is expected in the next year compared to the current price of 28.41.
The average price target has been revised downward by 5.14% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
76.80%
CZR was analyzed by 25 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about CZR.
In the previous month the buy percentage consensus was at a similar level.
CZR was analyzed by 25 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-18 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2026-02-18 | Macquarie | Maintains | Outperform -> Outperform |
| 2026-02-18 | Stifel | Maintains | Buy -> Buy |
| 2026-02-18 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-18 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-21 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-16 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-08 | Susquehanna | Upgrade | Neutral -> Positive |
| 2025-12-15 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-11-21 | Citigroup | Initiate | Neutral |
| 2025-11-18 | Wells Fargo | Initiate | Equal-Weight |
| 2025-11-04 | Jefferies | Downgrade | Buy -> Hold |
| 2025-10-29 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-29 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-10-29 | Stifel | Maintains | Buy -> Buy |
| 2025-10-29 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-21 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-17 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-10-08 | Stifel | Maintains | Buy -> Buy |
| 2025-09-16 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 27, 2026
PeriodQ1 / 2026
EPS Estimate-$0.26
Revenue Estimate2.871B
Revenue Q2Q2.76%
EPS Q2Q52.13%
Number of Analysts17
Next Earnings Revisions
Revenue (1 Month)
-0.86%
Revenue (3 Months)
-1.17%
EPS (1 Month)
-55.48%
EPS (3 Months)
-127.77%
Next Earnings Summary
CZR is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is -0.26 USD and the consensus revenue estimate is 2.87B USD.
The next earnings revenue estimate has been revised downward by 1.17% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.528B 6.53% | 11.245B -2.45% | 11.486B 2.14% | 11.893B 3.54% | 12.186B 2.46% | 12.471B 2.34% | 13.246B 6.21% | 13.475B 1.73% | 13.822B 2.58% | 14.179B 2.58% | 14.547B 2.60% | |
| EBITDA YoY % growth | 3.815B 24.43% | 3.599B -5.66% | 3.495B -2.89% | 3.79B 8.44% | 3.913B 3.25% | 4.03B 2.99% | 4.525B 12.28% | 4.628B 2.28% | 4.78B 3.28% | 4.925B 3.03% | 5.066B 2.86% | |
| EBIT YoY % growth | 2.554B 37.24% | 2.275B -10.92% | 2.078B -8.66% | 2.241B 7.84% | 2.351B 4.91% | 2.494B 6.08% | 2.79B 11.87% | 2.862B 2.58% | 2.984B 4.26% | 3.082B 3.28% | 3.19B 3.50% | |
| Operating Margin | 22.15% | 20.23% | 18.09% | 18.84% | 19.29% | 20.00% | 21.06% | 21.24% | 21.59% | 21.74% | 21.93% | |
| EPS YoY % growth | -0.72 82.90% | -0.74 -2.78% | -2.43 -228.38% | -0.08 96.76% | 0.65 920.05% | 1.22 89.01% | 3.83 213.48% | 4.38 14.51% | 5.39 23.04% | 6.74 24.91% | 7.76 15.14% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 52.13% | 0.14 136.09% | 0.05 119.96% | 0.14 111.23% | 0.00 99.22% | 0.22 56.19% | 0.20 266.06% | 0.30 117.87% |
| Revenue Q2Q % growth | 2.871B 2.76% | 2.994B 2.99% | 2.992B 4.29% | 3.016B 3.43% | 2.927B 1.95% | 3.013B 0.63% | 3.009B 0.57% | 2.989B -0.90% |
| EBITDA Q2Q % growth | 890.98M 5.19% | 982.03M -23.34% | 918.24M -41.74% | 927.35M -52.25% | 927.13M 4.06% | 991.74M 0.99% | 976.6M 6.36% | 980.73M 5.76% |
| EBIT Q2Q % growth | 517.4M 5.59% | 597.05M 6.62% | 584.04M 16.11% | 609.17M 16.03% | 578M 11.71% | 627.17M 5.04% | 618.26M 5.86% | 648.79M 6.50% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
35.77%
EPS Next 5 Year
30.63%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
2.53%
Revenue Next 5 Year
3.10%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
24.69%
EBIT Next 5 Year
17.36%
CAESARS ENTERTAINMENT INC / CZR Forecast FAQ
What is the price target for CZR stock?
25 analysts have analysed CZR and the average price target is 34.26 USD. This implies a price increase of 20.6% is expected in the next year compared to the current price of 28.41.
What is the next earnings date for CZR stock?
CAESARS ENTERTAINMENT INC (CZR) will report earnings on 2026-04-27, after the market close.
Can you provide the consensus estimates for CAESARS ENTERTAINMENT INC next earnings?
The consensus EPS estimate for the next earnings of CAESARS ENTERTAINMENT INC (CZR) is -0.26 USD and the consensus revenue estimate is 2.87B USD.
What is the number of analysts for CZR stock?
The number of analysts covering CAESARS ENTERTAINMENT INC (CZR) is 25.